We're all set for a new experience. To visit the old Ventura website, click here.
Ventura Wealth Clients Login here

NSEBSE
NSEBSE
noteThere is a 15-minute delay in the prices. To check out the live prices, log in to your Ventura account or open one today.
1D
1W
1M
1Y
3Y
5Y
Max
Open2,565
High2,578.6
Low2,528.1
Prev. Close2,556.9
Avg. Traded Price2,552.59
Volume23,220

MARKET DEPTH

info2
Total bid13,639.00
Total ask14,503.00
OrdersQtyBid
112562.2
112561.7
182561.6
2222561.5
2172561.4
AskQtyOrders
2563.122
2563.711
2563.811
2563.925
256429

HIGH/LOW

info2
1d
1w
1m
3m
52w

LOW/HIGH

2,528.1027 minutes ago
2,578.6027 minutes ago
arrow

LOWER/UPPER CIRCUITS

2,045.60
3,068.20
arrow
Mankind Pharma Limited Stock performance
arrow

KEY OBSERVATIONS

info
positive
negative
neutral
noteAnnual Revenue,rose 19.57%, in the last year to ₹10,615.63 Cr. Its sector's average revenue growth for the last fiscal year was 12.27%.
noteAnnual Net Profit,rose 49.23% in the last year to ₹1,912.9 Cr. Its sector's average net profit growth for the last fiscal year was 29.44%.
noteReturn on Equity(ROE),for the last financial year was 20.43%, more than 20% in the last financial year, indicating an efficient use of shareholder's capital to generate profit.
View more

STOCK RETURNS

info
Versus Nifty 50
1 w
-1.19%
vs
-0.36%
1 mth
+5.47%
vs
+2.21%
3 mth
+4.10%
vs
+4.71%
6 mth
+5.39%
vs
-1.23%
1 yr
+7.59%
vs
+6.16%
3 yr
vs
+39.4%
5 yr
vs
+156.26%

ANALYST RATING

Aggregated across 100 coverages
Buy
Hold
Sell
66.67%
33.33%
0%
Powered by Trendlyne.
Mankind Pharma Limited is engaged in developing, manufacturing and marketing a diverse range of pharmaceutical formulations across various acute and chronic therapeutic areas, as well as several consumer healthcare products. The company is engaged in developing, manufacturing and marketing a diverse range of pharmaceutical formulations across various acute and chronic therapeutic areas, as well as several consumer healthcare products. It operates at the intersection of the Indian pharmaceutical formulations and consumer healthcare sectors with the aim of providing quality products at affordable prices, and has an established track record of building and scaling brands in-house. It has created many brands in its pharmaceutical business.
personal

Grow your wealth with more research recommendations

+91